# CK19 Combined With Contrast-enhanced Ultrasound: a Prediction System on Axillary Lymph Node Metastasis in Breast Cancer

> **NCT02992067** · — · COMPLETED · sponsor: **Zhejiang Cancer Hospital** · enrollment: 359 (actual)

## Conditions studied

- Lymph Node
- Breastcancer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02992067
- **Lead sponsor:** Zhejiang Cancer Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2015-04
- **Primary completion:** 2017-04
- **Final completion:** 2017-07
- **Target enrollment:** 359 (ACTUAL)
- **Last updated:** 2019-10-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02992067

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02992067, "CK19 Combined With Contrast-enhanced Ultrasound: a Prediction System on Axillary Lymph Node Metastasis in Breast Cancer". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02992067. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*